Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Capital Expenditures (2022 - 2024)

Historic Capital Expenditures for HeartSciences (HSCS) over the last 3 years, with Q2 2024 value amounting to $48799.0.

  • HeartSciences' Capital Expenditures rose 54276.87% to $48799.0 in Q2 2024 from the same period last year, while for Apr 2025 it was $57593.0, marking a year-over-year decrease of 1064.62%. This contributed to the annual value of $3157.0 for FY2025, which is 9510.2% down from last year.
  • According to the latest figures from Q2 2024, HeartSciences' Capital Expenditures is $48799.0, which was up 54276.87% from $8794.0 recorded in Q1 2024.
  • In the past 5 years, HeartSciences' Capital Expenditures registered a high of $48799.0 during Q2 2024, and its lowest value of $1952.0 during Q4 2023.
  • Moreover, its 3-year median value for Capital Expenditures was $7247.0 (2022), whereas its average is $11823.3.
  • Per our database at Business Quant, HeartSciences' Capital Expenditures plummeted by 3224.78% in 2023 and then skyrocketed by 54276.87% in 2024.
  • Over the past 3 years, HeartSciences' Capital Expenditures (Quarter) stood at $7247.0 in 2022, then plummeted by 73.06% to $1952.0 in 2023, then surged by 2399.95% to $48799.0 in 2024.
  • Its Capital Expenditures stands at $48799.0 for Q2 2024, versus $8794.0 for Q1 2024 and $1952.0 for Q4 2023.